Ars Pharmaceuticals Inc. (SPRY)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Deerfield Management

James E. Flynn

11,077,927 $60,707,040 1.12%
2.
RA Capital Management

Peter Kolchinsky

9,459,678 $51,839,035 0.8%
3.
OrbiMed Advisors

Samuel Isaly

9,240,887 $50,640,061 1.01%
4.
Baker Bros. Advisors

Julian Baker And Felix Baker

2,006,451 $10,995,351 0.12%
5.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

1,596,504 $8,748,842 +46% 0.52%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.79 505,954 9,958,073 2024-03-27 Filing
$9.55 457,745 9,452,119 2024-03-26 Filing
$9.06 437,600 8,994,374 2024-03-25 Filing
$3.78 46,258 Officer 89,227 2023-09-29 Filing
$3.62 40,000 Officer 42,969 2023-09-28 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.28 50,000 1,848,499 2024-04-16 Filing
$9.28 50,000 1,647,447 2024-04-16 Filing
$9.28 50,000 1,848,499 2024-04-16 Filing
$9.28 50,000 1,647,447 2024-04-16 Filing
$9.28 50,000 1,898,499 2024-04-09 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 4,098,497 $22,459,764 0.01%
2. 4,012,903 $21,990,708 9.23%
3. 3,996,071 $21,898,469 2.15%
4. 3,054,333 $16,737,745 2.13%
5. 2,637,549 $14,453,768 0%
News See All